Transparency Market Research
Transdermal Drug Delivery Market - Global and China Forecast, Share, Size, Growth and Industry Analysis 2010 - 2017
Albany, New York (PRWEB) June 05, 2014
Transdermal Drug Delivery eliminates the issues related with oral and injectable methods of drug delivery as the drugs are injected through the skin of the patient. Some of the major factors increasing its adoption across the globe include reduction in side effects, improvement in effectiveness of therapy as it leads to uniform plasma levels and also improves bioavailability. Daily advances in Transdermal drug delivery systems will improve the quality of life. Transdermal Drug Delivery Market is set to rise in the coming years due to its applicability in areas like wound care, women’s health, monitoring and various diagnostic methods.
Browse the full report: http://www.transparencymarketresearch.com/transdermal-drug-delivery-market.html.
The report contains the global scenario of Transdermal Drug Delivery market discussing detailed overview and market figures. The research report analyses the industry growth rate, industry capacity, and industry structure. The report analyses the historical data and forecasts the Transdermal Drug Delivery market size, production forecasts along with key factors driving and restraining the market.
Introduction
1.1. Key takeaways
1.2. Report description
1.3. Research methodology
1.4. Stakeholders
1.5. Key definitions
1.6. Forecast assumptions
2. Executive summary
3. Market overview
3.1. Market dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunities
3.2. Impact analysis of drivers
3.3. Impact analysis of restraints
3.4. Shifting demographic trends
3.5. Transdermal technology overview
3.6. Advantages of transdermal drug delivery systems
3.7. Fda regulations
3.8. Clinical trial process
3.9. Key issues faced
3.10. Therapeutic focus
3.11. Geographic analysis of sales
3.12. Leading players
3.13. Value chain analysis
3.14. Market share analysis
3.15. Five force analysis
3.15.1. Bargaining power of suppliers
3.15.2. Bargaining power of buyers
3.15.3. Threat of substitutes
3.15.4. Threat from new entrants
3.15.5. Intense of competitive rivalry
4. Market analysis
4.1. Market size and growth
4.1.1. Transdermal drug delivery market
4.1.2. Transdermal drug delivery market by geography
4.1.2.1. U.s.
4.1.2.1.1. Market overview and trends
4.1.2.2. Europe
4.1.2.2.1. Market overview and trends
4.1.2.3. Asia-pacific
4.1.2.3.1. Market overview and trends
4.1.2.4. Row
4.1.2.4.1. Market overview and trends
4.2. Transdermal technologies
4.2.1. Electric current
4.2.2. Electroporation
4.2.3. Microporation
4.2.4. Mechanical arrays
4.2.5. Radio frequency
4.2.6. Lontophoresis
4.2.7. Thermal
4.2.8. Ultrasound
4.3. Product analysis
4.3.1. Pain management
4.3.2. Cns
4.3.3. Cardiovascular
4.3.4. Hormone
4.3.5. Others
4.3.6. Pipeline overview
5. Recommendations
6. Competitive landscape
6.1. Key mergers and acquisitions
6.2. Technological innovations in transdermal drug delivery
6.3. Agreements
7. Company profiles
7.1. Novartis
7.2. Johnson & johnson
7.3. Mylan
7.4. Watson
7.5. Skyepharma plc
7.6. Transdermal technologies, inc.
7.7. Biogel technology, inc.
7.8. Boehringer ingelheim
Browse the full report: http://www.transparencymarketresearch.com/transdermal-drug-delivery-market.html.